Alternatives to Myonal (Eperisone) for Muscle Relaxation

First-Line Alternatives

The American College of Physicians recommends cyclobenzaprine as an effective option for acute low back pain, though clinicians should be aware it is structurally identical to amitriptyline and carries similar adverse effects including sedation 1, 4.
Cyclobenzaprine is the most evidence-supported alternative for short-term relief (up to 2-3 weeks) of acute skeletal muscle pain, according to the Journal of the American Geriatrics Society and Annals of Internal Medicine 1, 3.
Methocarbamol and metaxalone are equally effective alternatives without the tricyclic antidepressant structure, providing short-term pain relief with fewer central nervous system effects compared to other agents 2, 3.

The American Geriatrics Society suggests baclofen as the preferred agent when actual muscle spasm (rather than nonspecific muscle pain) is suspected, with documented efficacy for severe spasticity from central nervous system injury, demyelinating conditions, and other neuromuscular disorders 1, 4.
Tizanidine is an emerging alternative with evidence for perioperative benefit, including improved postoperative pain control and decreased opioid consumption, according to Praxis Medical Insights 2.

Benzodiazepines should generally be avoided as they do not provide direct analgesic effects and carry high risk profiles in older adults, according to the Journal of the American Geriatrics Society and Annals of Internal Medicine 1, 3, 4.
Chlorzoxazone and other non-specific agents have nonspecific effects not actually related to muscle relaxation and should not be prescribed under the mistaken belief that they relieve muscle spasm, according to the Journal of the American Geriatrics Society 1, 4.

Limit muscle relaxant use to short-term therapy (2-3 weeks maximum), as the effectiveness of muscle relaxants in long-term use beyond 4 months has not been assessed by systematic clinical studies 2, 3.
All muscle relaxants are associated with greater risk for falls in older persons, and when muscle relaxation is necessary in elderly patients, baclofen is the preferred agent starting at 5 mg three times daily with gradual titration 1, 2, 4.
Neuromuscular blockade monitoring is essential when using muscle relaxants in patients with neuromuscular disease, as pharmacodynamic changes are significant, according to Anaesthesia 5, 6, 7, 8, 9.
NSAIDs or acetaminophen should be considered as first-line therapy before any muscle relaxant, given comparable efficacy and superior safety profiles, according to Praxis Medical Insights 2.